Bio-Techne TECH EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Bio-Techne’s reported figures.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's EBITDA?
- Bio-Techne (TECH) reported EBITDA of $99.66M in Q1 2026.
- How has Bio-Techne's EBITDA changed year-over-year?
- Bio-Techne's EBITDA increased by 50.4% year-over-year, from $66.28M to $99.66M.
- What is the long-term trend for Bio-Techne's EBITDA?
- Over 2 years (2022 to 2024), Bio-Techne's EBITDA has grown at a -10.5% compound annual growth rate (CAGR), from $397.66M to $318.4M.
- What does EBITDA mean?
- Operating cash profit before interest, taxes, and non-cash charges.
- How do you interpret EBITDA?
- Higher is better and widely used to value capital-intensive businesses, but it ignores the real cost of capex — pair it with free cash flow. (Defined as EBIT + D&A so EBITDA = EBIT + D&A holds exactly.)
- How does EBITDA compare across companies?
- Standard cross-company operating-profit proxy for non-financials; not meaningful for banks and insurers.